Deferasirox | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Deferasirox
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

Zhejiang Hengkang Deferasirox

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Deferasirox

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

71 API Suppliers, 23 USDMF, 10 CEP/COS, 1 JDMF, 24 EU WC, 16 KDMF, 19 NDC API, 52 Listed Suppliers, $ API Reference Price

71 API Suppliers
23 USDMF
10 CEP/COS
1 JDMF
24 EU WC
16 KDMF
19 NDC API
52 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

32 Intermediates Suppliers

32 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

375 FDF Dossiers, 107 FDA Orange Book, 46 Europe, 30 Canada, 144 Australia, 7 South Africa, 41 Listed Dossiers

375 FDF Dossiers
107 FDA Orange Book
46 Europe
30 Canada
144 Australia
7 South Africa
41 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

GRANULE;ORAL - 180MG, GRANULE;ORAL - 360MG, GRANULE;ORAL - 90MG

GRANULE;ORAL - 180MG
GRANULE;ORAL - 360MG
GRANULE;ORAL - 90MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 3 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 4 DFE Pharma, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 17 Kerry, 9 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 7 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 9 Sigachi Industries, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

1 SPI Pharma
1 DKSH
3 Faran Shimi Pharmaceutical
3 Boai NKY Pharmaceuticals Ltd
8 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
6 BASF
4 DFE Pharma
4 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
17 Kerry
9 Microlex e.U
1 Nanjing Bold Chemical
1 Pharmatrans-Sanaq
3 Pluviaendo
2 Prachin Chemical
7 Roquette
3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shanghai Welltone Material Technology Co., Ltd
9 Sigachi Industries
1 Ulanqab Kema New Material
2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Fillers, Diluents & Binders, 20 Direct Compression, 14 Lubricants & Glidants, 13 Co-Processed Excipients, 12 Thickeners and Stabilizers, 12 Granulation, 5 Controlled & Modified Release, 5 Disintegrants & Superdisintegrants, 4 Emulsifying Agents, 4 Coating Systems & Additives, 4 Taste Masking, 2 Chewable & Orodispersible Aids, 2 Parenteral, 2 Film Formers & Plasticizers, 2 API Stability Enhancers, 2 Solubilizers, 2 Topical, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers

42 Fillers, Diluents & Binders
20 Direct Compression
14 Lubricants & Glidants
13 Co-Processed Excipients
12 Thickeners and Stabilizers
12 Granulation
5 Controlled & Modified Release
5 Disintegrants & Superdisintegrants
4 Emulsifying Agents
4 Coating Systems & Additives
4 Taste Masking
2 Chewable & Orodispersible Aids
2 Parenteral
2 Film Formers & Plasticizers
2 API Stability Enhancers
2 Solubilizers
2 Topical
1 Surfactant & Foaming Agents
1 Rheology Modifiers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 59 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
59 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 42 Finished Drug Prices, 9 Annual Reports

3 US Medicaid Prescriptions
42 Finished Drug Prices
9 Annual Reports

MARKET PLACE

10 APIs, 3 FDF Dossiers

10 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 6 Health Canada Patents

3 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

16 Others

16 Others

$ API Ref.Price (USD/KG) : 405 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Gowling WLG (Canada) LLP

filter Patent Reset all filters

6 All

01 62255951

filter Product Reset all filters

6 All

01 3DEFERASIROX

02 3Deferasirox

filter Dosage Reset all filters

6 All

01 1Dispersible Tablet for Oral Suspension

02 2Dispersible Tablets for Oral Suspension

03 3TABLET

filter Exp Date Reset all filters

6 All

01 62017-06-24

Synnat Deferasirox

Product Main Page

01

Gowling WLG (Canada) LLP

Deferasirox

Pharmtech & Ingredients

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-06-24

Date Granted : 2006-10-10

Deferasirox

Brand Name : EXJADE

Patent Number : 2255951

Filing Date : 1997-06-24

Strength per Unit : 125 mg

Dosage Form : Dispersible Tablet for Oral Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-06-24

Date Granted : 2006-10-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Deferasirox

Pharmtech & Ingredients

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-06-24

Date Granted : 2006-10-10

Deferasirox

Brand Name : EXJADE

Patent Number : 2255951

Filing Date : 1997-06-24

Strength per Unit : 250 mg

Dosage Form : Dispersible Tablets for Oral Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-06-24

Date Granted : 2006-10-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling WLG (Canada) LLP

Deferasirox

Pharmtech & Ingredients

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-06-24

Date Granted : 2006-10-10

Deferasirox

Brand Name : EXJADE

Patent Number : 2255951

Filing Date : 1997-06-24

Strength per Unit : 500 mg

Dosage Form : Dispersible Tablets for Oral Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-06-24

Date Granted : 2006-10-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling WLG (Canada) LLP

Deferasirox

Pharmtech & Ingredients

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-06-24

Date Granted : 2006-10-10

Deferasirox

Brand Name : JADENU

Patent Number : 2255951

Filing Date : 1997-06-24

Strength per Unit : 360 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2017-06-24

Date Granted : 2006-10-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Gowling WLG (Canada) LLP

Deferasirox

Pharmtech & Ingredients

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-06-24

Date Granted : 2006-10-10

Deferasirox

Brand Name : JADENU

Patent Number : 2255951

Filing Date : 1997-06-24

Strength per Unit : 90 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2017-06-24

Date Granted : 2006-10-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Gowling WLG (Canada) LLP

Deferasirox

Pharmtech & Ingredients

Not Confirmed

Gowling WLG (Canada) LLP

Canada

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-06-24

Date Granted : 2006-10-10

Deferasirox

Brand Name : JADENU

Patent Number : 2255951

Filing Date : 1997-06-24

Strength per Unit : 180 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2017-06-24

Date Granted : 2006-10-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?